# Evaluation of the Omission of Dexamethasone in Premedication Regimens During Paclitaxel Treatment

> **NCT06118710** · PHASE4 · RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 500 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** H1 Antihistaminics

## Key facts

- **NCT ID:** NCT06118710
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-25
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06118710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06118710, "Evaluation of the Omission of Dexamethasone in Premedication Regimens During Paclitaxel Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06118710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*